A phase 1b study to evaluate safety, tolerability, pharmacokinetics and clinical efficacy of the nucleotide-binding oligomerization domain, leucine rich repeat containing x1 (nlrx1) agonist nx-13 in ulcerative colitis
GASTROENTEROLOGY（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要